Streptococcus pneumoniae (SOUTHEAST Data) | |||||||
2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | |
penicillin | 51.6% n=657 | 48.8% n=763 | 50% n=488 | 53% n=549 | 46.8% n=325 | 54.8% n=124 | 53.2% n=94 |
amoxicillin/clavulanate | 97.7% n=87 | 95.5% n=88 | 96.8% n=154 | 96.1% n=179 | 93.1% n=29 | 81.3% n=107 | 86.2% n=94 |
ampicillin | 88% n=25 | 100% n=87 | |||||
vancomycin | 100% n=587 | 100% n=680 | 100% n=477 | 100% n=505 | 100% n=533 | 100% n=112 | 100% n=94 |
cefaclor | 60.9% n=23 | 66.7% n=63 | |||||
cefuroxime | 69.2% n=214 | 67.2% n=119 | 63.5% n=271 | 67.2% n=232 | 53.8% n=199 | 70.2% n=124 | 60.6% n=94 |
cefotaxime | 89.4% n=236 | 80.2% n=227 | 81.6% n=87 | 84.7% n=131 | 87.8% n=49 | 80% n=125 | 74.5% n=94 |
ceftriaxone | 90% n=482 | 88.7% n=653 | 88.1% n=427 | 84.6% n=403 | 83.6% n=305 | 80% n=125 | 76.6% n=94 |
clindamycin | 98.3% n=59 | 99% n=97 | 98.1% n=54 | 78.9% n=90 | 88.6% n=88 | 67.3% n=107 | 74.5% n=94 |
erythromycin | 65.7% n=356 | 63.1% n=452 | 62.2% n=188 | 65.1% n=209 | 54.7% n=362 | 40.2% n=107 | 40.4% n=94 |
azithromycin | 55.9% n=68 | 57% n=93 | 55.2% n=29 | 39.8% n=108 | 40.4% n=94 | ||
levofloxacin | 98.7% n=377 | 98.8% n=426 | 97.1% n=278 | 99% n=305 | 97.8% n=360 | 99.2% n=125 | 97.9% n=94 |
gatifloxacin | 98.3% n=59 | 100% n=66 | 98.1% n=54 | 98.2% n=56 | 96.2% n=26 | ||
TMP/SMX | 63.6% n=349 | 67.4% n=380 | 62.4% n=229 | 64.7% n=266 | 58.6% n=324 | 37.1% n=124 | 57.4% n=94 |
chloramphenicol | 94.3% n=35 | 93.2% n=221 | 96% n=25 | 90.6% n=64 | 92.3% n=78 | ||
Totals | 79.5% n=3498 | 79.3% n=4172 | 78.1% n=2848 | 79% n=3232 | 75.2% n=2629 | 69.8% n=1366 | 69.2% n=1034 |
This data is accurate as of: 11/22/2016 11:53:58 AM
Drugs with less than 10 isolates are removed from the chart and from the graph. The following drugs had some data removed: amoxicillin/clavulanate, cefazolin, clindamycin, gatifloxacin, chloramphenicol, ampicillin, cefaclor, cefotaxime, azithromycin, penicillin, vancomycin, cefuroxime, ceftriaxone, erythromycin, levofloxacin, TMP/SMX.